Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (12): 1409-1414.doi: 10.12092/j.issn.1009-2501.2023.12.011

Previous Articles     Next Articles

Research progress on the role of melatonin in the treatment of ischemia-reperfusion injury

JIN Xuelei, LU Yapeng, DI Xuerui, ZHENG Qihui, SHI Yisa   

  1. Department of Anestheiology, Lanzhou University Second Hospital, Lanzhou 730000, Gansu, China 
  • Received:2023-07-05 Revised:2023-07-30 Online:2023-12-26 Published:2023-12-21

Abstract:

Ischemia-reperfusion (I/R) is a complex hemodynamic process that can cause tissue damage through oxidative stress, mitochondrial dysfunction, and inflammatory reactions. It is an important factor leading to poor prognosis in patients, and the exploration of effective prevention and treatment measures is of significant clinical significance.As an endogenous hormone with strong antioxidant and anti-inflammatory properties, Melatonin plays an important role in reducing cell death and improving tissue I/R injury. Therefore, this article reviews the relationship between Melatonin and organ I/R injury in order to provide a theoretical basis for the clinical application of melatonin to alleviate organ I/R injury.

Key words: melatonin, ischemia reperfusion injury, organ protection

CLC Number: